Perachino M, Eandi M. The utility of a model-based cost-effectiveness analysis of degarelix versus leuprolide in the therapy of hormone-dependent advanced prostate cancer. Farmeconomia. Health Economics and Therapeutic Pathways. 2013;14(3):131-146. https://doi.org/10.7175/fe.v14i3.700